 Tatva Chintan Pharma Chem Ltd consolidated Q2FY26 PAT climbs to Rs. 9.91 crores
Tatva Chintan Pharma Chem Ltd consolidated Q2FY26 PAT climbs to Rs. 9.91 crores GPT Infraprojects Ltd receives contract worth Rs. 37.8 crore
GPT Infraprojects Ltd receives contract worth Rs. 37.8 crore Dr Lal PathLabs Limited recommends 1:1 bonus issue
Dr Lal PathLabs Limited recommends 1:1 bonus issue RITES signs MoU with Shipping Corporation of India
RITES signs MoU with Shipping Corporation of India XTGlobal announces new client win for Circulus AP Automation Solution in the U.S. Construction Sector
XTGlobal announces new client win for Circulus AP Automation Solution in the U.S. Construction Sector 
              Mr. Krishnan ASV, Institutional Research Analyst, HDFC Securities and Deepak Shinde, Institutional Research Analyst, HDFC Securities
We expect our coverage universe to clock subdued PPOP growth of 6.9% YoY as business momentum is yet to fully recover from the second wave blues. With the second wave having receded after Q1FY22, we expect the pace of collections and recoveries to witness significant improvement, driving the stressed pool lower. However, complete normalisation of collection efficiency and reversion to business as usual (BAU) is likely to take another quarter, as the economy bounces to full-throttle mode. The incremental provisioning during Q2FY22 is likely to taper off, although lenders are likely to maintain a nominal surplus provisioning buffer. Disbursements are likely to witness healthy growth on the back of pent-up demand and gradual resumption of economic activity. We tweak our FY22E forecasts marginally for select lenders to factor in higher credit costs. We introduce FY24 estimates for our entire coverage universe and roll forward to Sep'23. We continue to favour large banks with strong balance sheets and formidable deposit franchises - ICICIBC (TP INR842) is our conviction pick, followed by SBIN (TP INR540) among large banks; CUBK (TP INR200) and FB (TP INR109) among mid-sized banks; and CIFC (TP INR 652) and CREDAG (TP INR 853) among NBFCs.